Antimicrobials for right-sided endocarditis in intravenous drug users: A systematic review

Journal of Antimicrobial Chemotherapy

Volumn 60, Issue 5, 2007, Pages 921-928

  Yung, Derek ^a   Kottachchi, Dan ^a   Neupane, Binod ^a   Haider, Shariq ^a   Loeb, Mark ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Antibiotics; IVDUs; Treatment

Indexed keywords

ANTIBIOTIC AGENT; CEFAPIRIN; CEFORANIDE; CEPHALOSPORIN; CIPROFLOXACIN; CLOXACILLIN; COTRIMOXAZOLE; DAPTOMYCIN; GENTAMICIN; NAFCILLIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; TEICOPLANIN; VANCOMYCIN;

CLINICAL TRIAL; COCHRANE LIBRARY; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; DRUG RESPONSE; DRUG TREATMENT FAILURE; EMBASE; ENDOCARDITIS; EVIDENCE BASED MEDICINE; EXTRAPULMONARY TUBERCULOSIS; HUMAN; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ABUSE; LONG TERM CARE; LOW DRUG DOSE; MEDLINE; META ANALYSIS; MONOTHERAPY; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCORING SYSTEM; SHORT COURSE THERAPY; SYSTEMATIC REVIEW; TREATMENT DURATION;

ANTI-BACTERIAL AGENTS; ENDOCARDITIS, BACTERIAL; HUMANS; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 35448962598     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm324     Document Type: Review

References (51)

1. Miro JM, del RA, Mestres CA. Infective endocarditis and cardiac surgery in intravenous drug abusers and HIV-1 infected patients. Cardiol Clin 2003; 21: 167-84, v-vi.
2. Miro JM, del RA, Mestres CA. Infective endocarditis in intravenous drug abusers and HIV-1 infected patients. Infect Dis Clin North Am 2002; 16: 273-95, vii-viii.
3. Moss R, Munt B. Injection drug use and right sided endocarditis. Heart 2003; 89: 577-81.
4. Verhagen DW, van der FM, Plokker HW et al. Optimisation of the antibiotic guidelines in The Netherlands. VII. SWAB guidelines for antimicrobial therapy in adult patients with infectious endocarditis. Neth J Med 2003, 61: 421-9.
5. Scheidegger C, Zimmerli W. Incidence and spectrum of severe medical complications among hospitalized HIV-seronegative and HIV-seropositive narcotic drug users. AIDS 1996; 10: 1407-14.
6. Spijkerman IJ, van Ameijden EJ, Mientjes GH et al. Human immunodeficiency virus infection and other risk factors for skin abscesses and endocarditis among injection drug users. J Clin Epidemiol 1996; 49: 1149-54.
7. Cherubin CE, Sapira JD. The medical complications of drug addiction and the medical assessment of the intravenous drug user: 25 years later. Ann Intern Med 1993; 119: 1017-28.
8. Haverkos HW, Lange WR. From the Alcohol, Drug Abuse, and Mental Health Administration. Serious infections other than human immunodeficiency virus among intravenous drug abusers. J Infect Dis 1990; 161 894-902.
9. Levine DP, Crane LR, Zervos MJ. Bacteremia in narcotic addicts at the Detroit Medical Center. II. Infectious endocarditis: A prospective comparative study. Rev Infect Dis 1986; 8: 374-96.
10. Reisberg BE. Infective endocarditis in the narcotic addict. Prog Cardiovasc Dis 1979; 22: 193-204.
11. Brown PD, Levine DP. Infective endocarditis in the injection drug user. Infect Dis Clin North Am 2002; 16: 645-65, viii-ix.
12. Frontera JA, Gradon JD. Right-side endocarditis in injection drug users: review of proposed mechanisms of pathogenesis. Clin Infect Dis 2000; 30: 374-9.
13. DeWitt DE, Paauw DS. Endocarditis in injection drug users. Am Fam Physician 1996; 53: 2045-9.
14. Berlin JA, Abrutyn E, Strom BL et al. Incidence of infective endocarditis in the Delaware Valley, 1988-1990. Am J Cardiol 1995; 76: 933-6.
15. Hecht SR, Berger M. Right-sided endocarditis in intravenous drug users. Prognostic features in 102 episodes. Ann Intern Med 1992; 117 560-6.
16. Crane LR, Levine DP, Zervos MJ et al. Bacteremia in narcotic addicts at the Detroit Medical Center. I. Microbiology, epidemiology, risk factors, and empiric therapy. Rev Infect Dis 1986; 8: 364-73.
17. Robbins MJ, Soeiro R, Frishman WH et al. Right-sided valvular endocarditis: Etiology, diagnosis, and an approach to therapy. Am Heart J 1986; 111: 128-35.
18. Prendergast BD. The changing face of infective endocarditis. Heart 2006; 92: 879-85.
19. Chambers HF, Korzeniowski OM, Sande MA. Staphlococcus aureus endocarditis: Clinical manifestations in addicts and nonaddicts. Medicine (Baltimore) 1983; 62: 170-7.
20. Abrams B, Sklaver A, Hoffman T et al. Single or combination therapy of staphylococcal endocarditis in intravenous drug abusers. Ann Intern Mad 1979; 90: 789-91.
21. Baddour LM, Wilson WR, Bayer AS et al. Infective endocarditis. Diagnosis, antimicrobial therapy, and management of complications: A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Curgery and Anesthesia, American Heart Association - Executive Summary: Endorsed by the Infectious Diseases Society of America. Circulation 2005; 111: 3167-84.
22. Dworkin RJ, Lee BL, Sande MA et al. Treatmenf of right-sided Staphylococcus aureus endocarditis in intravenous drug users with ciprofloxacin and rifampicin. Lancet 1989; II: 1071-3.
23. Elliott TS, Foweraker J, Gould FK et al. Guidelines for the anti-biotic treatment of endocarditis in adults: Report of the Working Party of the British Society for Antimicrobial Chemotherapy. J Antimicrob Chemother 2004; 54: 971-81.
24. Heldman AW, Hartert TV, Ray SC et al. Cral antibiotic treatment of right-sided staphylococcal endocarditis in injection drug users: prospective randomized comparison with parenteral therapy. Am J Med 1996; 101: 68-46.
25. Menda KB, Gorbach SL. Favorable experience with bacterial endocarditis in heroin addicts. Ann Intern Med 1973; 78: 25-32.
26. Chambers HF, Miller RT, Newman MD. Right-sided Staphylococcus aureus endocarditis in intravenous drug abusers: Two-week combination therapy. Ann Intern Med 1988; 109: 619-24.
27. DiNubile MJ. Abbreviated therapy for right-sided Staphylococcus aureus endocarditis in injecting drug users: The time has come? Eur J Clin Microbiol Infect Dis 1994; 13: 533-4.
28. DiNubile MJ. Short-course antibiotic therapy for right-sided endocarditis caused by Staphylococcus aureus in injection drug users. Ann Intern Med 1994; 121: 873-6.
29. Fortun J, Perez-Molina JA, Anon MT et al. Right-sided endocarditis caused by Staphylococcus aureus in drug abusers. Antimicrob Agents Chemother 1995; 39: 525-8.
30. Fortun J, Navas E, Martinez-Beltran J et al. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: Cloxacillin versus glycopeptides in combination with gentamicin. Clin Infect Dis 2001; 33: 120-5.
31. Ribera E, Gomez-Jimenez J, Cortes E et al. Effectiveness of cloxacillin with and without gentamicin in short-term therapy for right-sided Staphylococcus aureus endocarditis. A rindomized, controlled trial. Ann Intern Med 1996; 125: 969-74.
32. Torres-Tortosa M, de CM, Vergara A et al. Prospective evaluation of a two-week course of intravenous antibiotics in intravenous drug addicts with infective endocarditis. Grupo de Estudio de Enfermedades Infecciosas de la Provincia de Cadiz. Eur J Clin Microbiol Infect Dis 1994; 13: 559-64.
33. Espinosa FJ, Valdes M, Martin-Luengo F et al. Right endocarditis caused by Staphylococcus aureus in parenteral drug addicts: evaluation of a combined therapeutic scheme for 2 weeks versus conventional treatment. Enferm Infecc Microbiol Clin 1993; 11 235-40.
34. Higgins J, Green S, eds. Cochrane Handbook for Systematic Reviews of Interventions 4.2.6 (update September 2006). [4]. Chichester, UK: John-Wiley & Sons, Ltd, 2006.
35. Greenman RL, Arcey SM, Gutterman DA et al. Twice-daily intra-muscular ceforanide therapy of Staphylococcus aureus endocarditis in parenteral drug abusers. Antimicrob Agents Chemother 1984; 25: 16-9.
36. Markowitz N, Quinn EL, Saravolatz LD. Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection. Ann Intern Med 1992; 117: 390-8.
37. Fowler VG Jr, Boucher HW, Corey GR et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med 2006; 355: 653-65.
38. Murray RJ. Staphylococcus aureus infective endocarditis: Diagnosis management guidelines. Intern Med J 2005; 35 Suppl 2: S25-44.
39. Cantoni L, Wenger A, Glauser MP et al. Comparative efficacy of amoxicillin-clavulanate, cloxacillin, and vancomycin against methicillin-sensitive and methicillin-resistant Staphylococcus aureus endocarditis in rats. J Infect Dis 1989; 159: 989-93.
40. Garaud JJ, Regnier B, Lassoued K et al. Treatment of severe staphylococcal infections. Failure of rifampicin in combination therapy. 4 cases. Presse Med 1985; 14: 1013-6.
41. Geraci JE, Wilson WR. Vancomycin therapy for infective endocarditis. Rev Infect Dis 1981; 3 Suppl: S250-8.
42. Morris JG Jr, Tenney JH. Methicillin-resistant Staphylococcus aureus. Ann Intern Med 1983; 99: 283-4.
43. Small PM, Chambers HF. Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 1990; 34: 1227-31.
44. Falagas ME, Matthaiou DK, Bliziotis IA. The role of aminoglycosides in combination with a β-lactam for the treatment of bacterial endocarditis: A meta-analysis of comparative trials. J Antimicrob Chemother 2006; 57: 639-47.
45. Aldridge KE, Jones RN, Barry AL et al. In vitro activity of various antimicrobial agents against Staphylococcus aureus isolates including fluoroquinolone- and oxacillin-resistant strains. Diagn Microbiol Infect Dis 1992; 15: 517-21.
46. Brumfitt W, Hamilton-Miller JM. The challenge of methicillin-resistant Staphylococcus aureus. Drugs Exp Clin Res 1994; 20: 215-24.
47. Radberg G, Nilsson LE, Kihlstrom E et al. Frequencies of sub-populations of aminoglycoside- and vancomycin-resistant variants in Staphylococcus aureus and Staphylococcus epidermidis. J Antimicrob Chemother 1992; 30: 489-96.
48. Uete T, Matsuo K, Uete G. Cross-resistdrice of clinical isolates of methicillin-resistant Staphylococcus aureus to aminoglycosides and fluoroquinolones. Jpn J Antibiot 1992; 45: 943-8.
49. Watanakunakorn C, Glotzbecker C. Enhancement of antistaphylococcal activity of nafcillin and oxacillin by sisomicin and netilmicin. Antimicrob Agents Chemother 1977; 12: 346-8.
50. Coker AO. A study of synergism between cloxacillin and gentamicin on resistant staphylococci (penicillinase producing and gentamicin resistant). East Afr Med J 1989; 66: 141-7.
51. Korzeniowski O, Sande MA. Combination antimicrobial therapy for Staphylococcus aureus endocarditis in patients addicted to parenteral drugs and in nonaddicts: A prospective study. Ann Intern Med 1982; 97: 496-503.